Disclosure pertaining to approval by the Board of Neogen Morita New Materials Limited (NML) for issuance of equity shares of NML on Preferential Issue basis.

September 26, 2026 BSE Limited National Stock Exchange of India Limited Department of Corporate Services Listing Department, Exchange Plaza, Floor 25, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Bandra (East), Dalal Street, Mumbai 400 001 Mumbai – 400 051 Scrip Code No: 542665 Company Symbol: NEOGEN Debt Segment Code: 977028 Sub: Disclosure pursuant to regulation 30(9) read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”). Dear Sir/Madam, With reference to the captioned subject, we wish to inform you that the Board of Directors of Neogen Morita New Materials Limited (“NML”) – a wholly owned subsidiary of Neogen Ionics Limited (“NIL”) and the step- down subsidiary of Neogen Chemicals Limited (“the Company”) had at its meeting held today i.e., Saturday, September 26, 2026, inter alia considered and approved the issuance of 7,20,000 Equity Shares of NML of a face value of Rs. 10/- each (“Equity Shares”) at a price of Rs. 1,066.66 per Equity Share including a premium of Rs. 1,056.66 per Equity Share, rounded off to an aggregate amount of Rs. 76,80,00,000 (Rupees Seventy Six Crore Eighty Lakh only), on a preferential basis (“Preferential Issue”) to Morita Investment Limited (“MIL”) - a wholly owned subsidiary of Morita Chemicals Industries Co. Limited (“MCL”) in accordance with the Joint Venture Agreement entered into by NIL – a wholly owned subsidiary of the Company and MIL on August 31, 2025 and applicable provisions of the Companies Act, 2013 and other applicable laws, as amended, and subject to the approval of the Members of the Company and such other necessary approvals including requisite statutory and regulatory approvals, as may be required. The said Preferential Issue was also duly approved with requisite majority by the shareholders of NML at its Extra-Ordinary General Meeting held today i.e. Saturday, September 26, 2026. The details pursuant to Regulation 30 of the Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, as amended from time to time (“SEBI Circulars”), with respect to the aforesaid Preferential Issue is enclosed herewith as Annexure I. The above information is also being uploaded on the Company’s website at https://neogenchem.com/announcements/ under the other disclosure pursuant to regulation 30 tab and at the website of the NSE (www.nseindia.com) and BSE (www.bseindia.com). Kindly take the above information on your records. Thanking you, For Neogen Chemicals Limited Unnati Kanani Company Secretary & Compliance Officer Mem. No: A35131 Encl.: A/a Registered Office: 1002, Dev Corpora, Cadbury Junction, E: sales@neogenchem.com T: +91 22 2549 7300 Eastern Express Highway, Thane (W) 400 601, India. W: www.neogenchem.com F: +91 22 2549 7399 CIN No. L24200MH1989PLC050919 Annexure I Disclosure pursuant to Regulation 30 of the Listing Regulations read with SEBI Circular with respect to the preferential issue of the Equity Shares of Neogen Morita New Materials Limited (NML): PARTICULARS DETAILS Type of securities proposed to be Equity Shares of a Face Value of Rs. 10 each issued Type of issuance Preferential Issue in accordance with applicable provisions of the Companies Act, 2013 and rules made thereunder. Total number of securities proposed Issuance of 7,20,000 Equity Shares of NML of a face value of Rs. 10/- each on to be issued or the total amount for Preferential issue basis at a price of Rs. 1,066.66 per Equity Share including a which the securities will be issued premium of Rs. 1,056.66 per Equity Share, rounded off to an aggregate (approximately) amount of Rs. 76,80,00,000 (Rupees Seventy Six Crore Eighty Lakh only). Number of Proposed Allottee 1 (One) Name of proposed Allottee and maximum number of Equity Shares to be offered: Name of Proposed Allottee Maximum number of Equity Shares of NML to be offered Morita Investment Limited (“MIL”) - a wholly owned 7,20,000 subsidiary of Morita Chemicals Industries Co. Limited (“MCL”) Total 7,20,000 Post-allotment of securities: Outcome of subscription of Shares of NML Sr. No. Name of Proposed Allottee Category Pre- preferential allotment Post- preferential holding as on 26-09-2026 allotment holding No. % No. % 1. Morita Investment Limited (“MIL”) Non- Promoter 0 0 7,20,000 9.09 - a wholly owned subsidiary of Public Category Morita Chemicals Industries Co. Limited (“MCL”) Issue Price Issuance of 7,20,000 Equity Shares of NML of a face value of Rs. 10/- each on Preferential issue basis at a price of Rs. 1,066.66 per Equity Share including a premium of Rs. 1,056.66 per Equity Share, rounded off to an aggregate amount of Rs. 76,80,00,000 (Rupees Seventy Six Crore Eighty Lakh only). Lock in requirement Since NML is an unlisted public limited company, provisions pertaining to lock in requirements as mentioned in SEBI ICDR Regulations are not applicable. In case of convertibles, intimation on Not Applicable conversion of securities or on lapse of the tenure of the instrument Any cancellation or termination of Not Applicable proposal for issuance of securities including reasons thereof For Neogen Chemicals Limited Unnati Kanani Company Secretary & Compliance Officer Mem No: A35131 Registered Office: 1002, Dev Corpora, Cadbury Junction, E: sales@neogenchem.com T: +91 22 2549 7300 Eastern Express Highway, Thane (W) 400 601, India. W: www.neogenchem.com F: +91 22 2549 7399 CIN No. L24200MH1989PLC050919